{
 "drug": "Dexamethasone Sodium Phosphate Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "02/08/2019",
 "dayN": 2755,
 "cat": "Dermatology",
 "companies": [
  "Mylan Institutional, a Viatris Company",
  "Somerset Therapeutics, LLC",
  "Fresenius Kabi USA, LLC",
  "Hikma Pharmaceuticals USA, Inc.",
  "Eugia US LLC"
 ],
 "reasons": [
  "Demand increase for the drug"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "67457-422-54",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "800-796-9526",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA040803"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Mylan Institutional LLC"
    ],
    "product_ndc": [
     "67457-422",
     "67457-423",
     "67457-421",
     "67457-420"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "309696",
     "1116927",
     "1812194"
    ],
    "spl_id": [
     "dd5c82b6-a194-462c-9626-34a9b410cfea"
    ],
    "spl_set_id": [
     "dff598e8-e662-411f-978d-4ba3fb8ef7db"
    ],
    "package_ndc": [
     "67457-423-00",
     "67457-423-12",
     "67457-422-00",
     "67457-422-54",
     "67457-421-00",
     "67457-421-30",
     "67457-420-00",
     "67457-420-10"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54)",
   "company_name": "Mylan Institutional, a Viatris Company",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "70069-025-10",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "732-554-1037",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA211036"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Somerset Therapeutics, LLC"
    ],
    "product_ndc": [
     "70069-025"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "309696"
    ],
    "spl_id": [
     "0fefe630-0e29-4d04-a083-eb3036f48100"
    ],
    "spl_set_id": [
     "5a1b0266-90c8-4176-a6b0-c4204d3c604e"
    ],
    "package_ndc": [
     "70069-025-10"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "07/20/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 70069-025-10)",
   "company_name": "Somerset Therapeutics, LLC",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "76045-0210-10",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "0641-0367-25",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA087702"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-0367",
     "0641-6145",
     "0641-6146"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "309696",
     "1116927",
     "1812194"
    ],
    "spl_id": [
     "02bf3273-f0c8-448c-9f74-eb009fee9299"
    ],
    "spl_set_id": [
     "0277cc0a-2fd4-4605-a310-b613be84ee26"
    ],
    "package_ndc": [
     "0641-0367-21",
     "0641-0367-25",
     "0641-6145-01",
     "0641-6145-25",
     "0641-6146-01",
     "0641-6146-10",
     "0641-6146-25"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "76045-210-10",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA203129"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "76045-210"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "1812095"
    ],
    "spl_id": [
     "9af24370-ee9f-4005-b1e9-96eef58fbde5"
    ],
    "spl_set_id": [
     "ce25183b-cd67-4997-8de9-df59b750883b"
    ],
    "package_ndc": [
     "76045-210-00",
     "76045-210-10"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "67457-423-12",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "800-796-9526",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA040803"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Mylan Institutional LLC"
    ],
    "product_ndc": [
     "67457-423",
     "67457-422",
     "67457-421",
     "67457-420"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "309696",
     "1116927",
     "1812194"
    ],
    "spl_id": [
     "dd5c82b6-a194-462c-9626-34a9b410cfea"
    ],
    "spl_set_id": [
     "dff598e8-e662-411f-978d-4ba3fb8ef7db"
    ],
    "package_ndc": [
     "67457-423-00",
     "67457-423-12",
     "67457-422-00",
     "67457-422-54",
     "67457-421-00",
     "67457-421-30",
     "67457-420-00",
     "67457-420-10"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12)",
   "company_name": "Mylan Institutional, a Viatris Company",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "63323-516-10",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA040572"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-516",
     "63323-506"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "309696",
     "1812079"
    ],
    "spl_id": [
     "2ce90eb7-067d-4f1c-9184-c250e387e533"
    ],
    "spl_set_id": [
     "cca2c160-9188-48e8-9505-49a52388dcb7"
    ],
    "package_ndc": [
     "63323-506-00",
     "63323-506-01",
     "63323-506-03",
     "63323-506-13",
     "63323-516-01",
     "63323-516-10"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "67457-421-30",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "800-796-9526",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA040803"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Mylan Institutional LLC"
    ],
    "product_ndc": [
     "67457-421",
     "67457-423",
     "67457-422",
     "67457-420"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "309696",
     "1116927",
     "1812194"
    ],
    "spl_id": [
     "dd5c82b6-a194-462c-9626-34a9b410cfea"
    ],
    "spl_set_id": [
     "dff598e8-e662-411f-978d-4ba3fb8ef7db"
    ],
    "package_ndc": [
     "67457-423-00",
     "67457-423-12",
     "67457-422-00",
     "67457-422-54",
     "67457-421-00",
     "67457-421-30",
     "67457-420-00",
     "67457-420-10"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30)",
   "company_name": "Mylan Institutional, a Viatris Company",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "76045-212-10",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "888-386-1300",
   "availability": "Limited Availability",
   "related_info": "4 month expiry available on request. Next release not available at this time.",
   "openfda": {
    "application_number": [
     "ANDA209192"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "76045-212",
     "76045-109"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "2099700"
    ],
    "spl_id": [
     "6fd9ed0e-dddc-4e73-9442-49da54685f7b"
    ],
    "spl_set_id": [
     "4dd55929-fe0a-4884-ae0d-6f9435920eb7"
    ],
    "package_ndc": [
     "76045-109-01",
     "76045-109-10",
     "76045-212-00",
     "76045-212-10"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "76045-0212-10",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "888-386-1300",
   "availability": "Limited Availability",
   "related_info": "4 month expiry available on request. Next release not available at this time.",
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "63323-165-30",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "3 & 7 month expiry available on request. Check wholesalers for inventory.",
   "openfda": {
    "application_number": [
     "ANDA084916"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-165"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "1116927",
     "1812194"
    ],
    "spl_id": [
     "1815f54a-5637-45bc-a582-3e62350935ba",
     "9dd90418-e564-4bc5-9077-506a1c2c1bce"
    ],
    "spl_set_id": [
     "2b626a48-c7aa-4443-9164-a08ff069ccd1",
     "4fedef4f-ec96-4f36-b2f0-01e243e3b89e"
    ],
    "package_ndc": [
     "63323-165-11",
     "63323-165-51",
     "63323-165-13",
     "63323-165-53",
     "63323-165-02",
     "63323-165-01",
     "63323-165-03",
     "63323-165-05",
     "63323-165-30",
     "63323-165-16",
     "63323-165-26"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "70069-021-25",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "732-554-1019",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA207442"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Somerset Therapeutics, LLC"
    ],
    "product_ndc": [
     "70069-021"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "1812079"
    ],
    "spl_id": [
     "73618326-ff56-4a30-9d6d-6b019b61c2cd"
    ],
    "spl_set_id": [
     "799028e2-c0e4-494f-89ff-1b786babc34a"
    ],
    "package_ndc": [
     "70069-021-01",
     "70069-021-25"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "07/20/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25)",
   "company_name": "Somerset Therapeutics, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "55150-304-25",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "888-238-7880",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA210966"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Eugia US LLC"
    ],
    "product_ndc": [
     "55150-304"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "1812079"
    ],
    "spl_id": [
     "5d97a8a3-fd79-4fd1-8a0f-c8cf95d40964"
    ],
    "spl_set_id": [
     "29947f67-7868-40af-8ad2-a61f7149b44c"
    ],
    "package_ndc": [
     "55150-304-01",
     "55150-304-25"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "08/06/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25)",
   "company_name": "Eugia US LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "63323-165-01",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA084916"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-165"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "1116927",
     "1812194"
    ],
    "spl_id": [
     "1815f54a-5637-45bc-a582-3e62350935ba",
     "9dd90418-e564-4bc5-9077-506a1c2c1bce"
    ],
    "spl_set_id": [
     "2b626a48-c7aa-4443-9164-a08ff069ccd1",
     "4fedef4f-ec96-4f36-b2f0-01e243e3b89e"
    ],
    "package_ndc": [
     "63323-165-11",
     "63323-165-51",
     "63323-165-13",
     "63323-165-53",
     "63323-165-02",
     "63323-165-01",
     "63323-165-03",
     "63323-165-05",
     "63323-165-30",
     "63323-165-16",
     "63323-165-26"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "0641-6145-25",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA084282"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6145",
     "0641-0367",
     "0641-6146"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "309696",
     "1116927",
     "1812194"
    ],
    "spl_id": [
     "02bf3273-f0c8-448c-9f74-eb009fee9299"
    ],
    "spl_set_id": [
     "0277cc0a-2fd4-4605-a310-b613be84ee26"
    ],
    "package_ndc": [
     "0641-0367-21",
     "0641-0367-25",
     "0641-6145-01",
     "0641-6145-25",
     "0641-6146-01",
     "0641-6146-10",
     "0641-6146-25"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "67457-420-10",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "800-796-9526",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA040802"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Mylan Institutional LLC"
    ],
    "product_ndc": [
     "67457-420",
     "67457-423",
     "67457-422",
     "67457-421"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "309696",
     "1116927",
     "1812194"
    ],
    "spl_id": [
     "dd5c82b6-a194-462c-9626-34a9b410cfea"
    ],
    "spl_set_id": [
     "dff598e8-e662-411f-978d-4ba3fb8ef7db"
    ],
    "package_ndc": [
     "67457-423-00",
     "67457-423-12",
     "67457-422-00",
     "67457-422-54",
     "67457-421-00",
     "67457-421-30",
     "67457-420-00",
     "67457-420-10"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "08/20/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10)",
   "company_name": "Mylan Institutional, a Viatris Company",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "63323-165-05",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA084916"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-165"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "1116927",
     "1812194"
    ],
    "spl_id": [
     "1815f54a-5637-45bc-a582-3e62350935ba",
     "9dd90418-e564-4bc5-9077-506a1c2c1bce"
    ],
    "spl_set_id": [
     "2b626a48-c7aa-4443-9164-a08ff069ccd1",
     "4fedef4f-ec96-4f36-b2f0-01e243e3b89e"
    ],
    "package_ndc": [
     "63323-165-11",
     "63323-165-51",
     "63323-165-13",
     "63323-165-53",
     "63323-165-02",
     "63323-165-01",
     "63323-165-03",
     "63323-165-05",
     "63323-165-30",
     "63323-165-16",
     "63323-165-26"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "63323-506-01",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "ANDA040491"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-506",
     "63323-516"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "309696",
     "1812079"
    ],
    "spl_id": [
     "2ce90eb7-067d-4f1c-9184-c250e387e533",
     "756dda45-ea6d-4c90-a14a-18a78bf186a6"
    ],
    "spl_set_id": [
     "cca2c160-9188-48e8-9505-49a52388dcb7",
     "7cbd9005-7df2-47ee-adb3-7244c1c69bc3"
    ],
    "package_ndc": [
     "63323-506-00",
     "63323-506-01",
     "63323-506-03",
     "63323-506-13",
     "63323-516-01",
     "63323-516-10",
     "63323-506-41",
     "63323-506-16"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "02/08/2019",
   "package_ndc": "0641-6146-25",
   "generic_name": "Dexamethasone Sodium Phosphate Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "related_info": "Additional product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA084282"
    ],
    "brand_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "generic_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6146",
     "0641-0367",
     "0641-6145"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRA-ARTICULAR",
     "INTRALESIONAL",
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SOFT TISSUE"
    ],
    "substance_name": [
     "DEXAMETHASONE SODIUM PHOSPHATE"
    ],
    "rxcui": [
     "309696",
     "1116927",
     "1812194"
    ],
    "spl_id": [
     "02bf3273-f0c8-448c-9f74-eb009fee9299"
    ],
    "spl_set_id": [
     "0277cc0a-2fd4-4605-a310-b613be84ee26"
    ],
    "package_ndc": [
     "0641-0367-21",
     "0641-0367-25",
     "0641-6145-01",
     "0641-6145-25",
     "0641-6146-01",
     "0641-6146-10",
     "0641-6146-25"
    ],
    "unii": [
     "AI9376Y64P"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Dermatology",
    "Endocrinology/Metabolism",
    "Gastroenterology",
    "Hematology",
    "Neurology",
    "Oncology",
    "Ophthalmology",
    "Other",
    "Pulmonary/Allergy",
    "Rheumatology"
   ],
   "dosage_form": "Injection",
   "presentation": "Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  }
 ]
}